RxDoctor Payments Data

Bhargava Gannavarapu, MD

Gastroenterology · San Jose, CANPI 1881821825

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $24,726 of the $32,863 with a category attached, or 75.2%. Capsovision, Inc. accounts for 65.5% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2021 at $20,692 and has fallen 77.4% since, to $4,679 in 2025. Among gastroenterology clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$32,863in general payments, 2019–2025

Across 393 payments — averaging $83.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Capsovision, Inc.$22K
  • Olympus Medical Systems Corporation$3K
  • AbbVie$2K
  • Boston Scientific$2K
  • Gilead$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$807
  • plus $2K from 25 others
$40,856in research payments, 2019–2025

Across 7 payments — averaging $5836.64 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$41K

What the payments were for

  • Consulting fees$24,72675%
  • Travel & lodging$2091%
  • Food & beverage$7,77524%
  • Education$1520%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$32,863 in reported general payments places this provider in the 90th percentile of 1,885 gastroenterology providers in California.

See all gastroenterology providers in California →

Medicare billing

Part B allowed, 2024
$76,243
Medicare patients
173
Services billed
686

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Omeprazole67$964
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl23$383
Ondansetron OdtOndansetron14$212
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg13$201

Paid to pharmacies, not to this prescriber.

Other gastroenterology in San Jose

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →